Ppt electrosomes

1,152 views 17 slides Apr 23, 2020
Slide 1
Slide 1 of 17
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17

About This Presentation

ELECTOSOMES


Slide Content

COPS DSU DEPARTMENT OF PHARMACEUTICS PRESENTED BY: SAGAR.G M.PHARM,2nd SEM DEPARTMENT OF PHARMACEUTICS SUBMITTED TO : Dr.B. WILSON HEAD OF THE DEPARTMENT DEPARTMENT OF PHARMACEUTICS ELECTROSOMES

COPS DSU DEPARTMENT OF PHARMACEUTICS CONTENTS INTRODUCTION METHOD OF PREPARATION ADVANTAGES OF ELECTROSOMES DISADVANTAGES OF ELECTROSOMES APPLICATION REFERENCE

COPS DSU DEPARTMENT OF PHARMACEUTICS INTRODUCTION • These are the transmembrane protein generate and propagate the electrical signals that allow us to sense our surroundings, process, information, make decisions, and move. • Ion channel proteins act as gates that span the lipid bilayer that surrounds all electrochemical gradients. • The ion flux through a channel pore can be extremely high. • They are high resolution in function and 3D structure to description of their molecules. • The high resolution structure of ion channel and ion channel associated protein are providing the substrates for sophisticated tests of the mechanisms of channel gating and permeation. • Ion perform two basic function open and close to control the passage of ion across the cell membrane.

COPS DSU DEPARTMENT OF PHARMACEUTICS Extracellular Activation signal (voltage charges, ligand binding, second messenger) Cytoplasm

COPS DSU DEPARTMENT OF PHARMACEUTICS The electrosomes, a novel surface-display system based on the specific interaction between the cellulosomal scaffoldin protein and a cascade of redox enzymes that allows multiple electron-release by fuel oxidation. The electrosomes is composed of two compartment: (i) a hybrid anode, which consists of dockerin-containing enzymes attached specifically to cohesin sites in the scaffoldin to assemble an ethanol oxidation cascade, and (ii) a hybrid cathode, which consists of a dockerin-containing oxygen- reducing enzyme attached in multiple copies to the cohesin-bearing scaffoldin.

COPS DSU DEPARTMENT OF PHARMACEUTICS The electrosomes was designed for use both in an anode and a cathode compartment; in each compartment, the unique attributes of the cellulosome scaffoldin give a different advantage In the anode, the ethanol oxidation cascade consists of two enzymes, ADH and formaldehyde dehydrogenase (FormDH), both containing a different dockerin module of Acetivibrio cellulolyticus and of Clostridium thermocellum, C. thermocellum (zADH-Ac and pFormDH-Ct), respectively, assembled on a ‘designer’-scaffoldin chimera displayed on the surface of S. cerevisiae. At the cathode, copper oxidase (CueO) was selected for surface-display. CueO is a multi- copper oxidase enzyme expressed by E. coli that catalyses the oxidation of Cu(I) ions coupled to oxygen reduction to water. The different constructs used for assembly are depicted. We report the characterization of the dockerin-containing enzymes and their electrochemical activity using a diffusing redox mediator.

COPS DSU DEPARTMENT OF PHARMACEUTICS + TARGET PROTEIN NANOCARRIER DIFFERENT LOADING TECHNIQUES DIRECT CONJUGATION METHOD PHYSICAL ABSORPTION METHOD ENCAPSULATION

COPS DSU DEPARTMENT OF PHARMACEUTICS Structure of ELECTROSOMES Ion channels are the part of large protein network. These networks includes cytoskeletonComponents , singling proteins like protein kinase and phosphates, and channel-associated proteins that recruit singling molecules to the channel to modify its function. Gold nanoparticle Physicochemical properties: Shape, size, surface coating Etc. Experimental condition: Administration route, dose, Animal species, exposure duration, etc. Pharmacokinetics and biodistribution Tumor targeting (EPR effect) Liver uptake (RES) Penetration of biological barriers (eg.BBB) Renal clearance Metabolism Biological effects Therapeutic efficacy Toxicity { Cytotoxicity In vivo toxicity

COPS DSU DEPARTMENT OF PHARMACEUTICS METHOD OF PREPARATION 1.Strains and Constructs method. 2.Enzyme Binding to Scaffoldin. 3.Biofuel-Cell Assembly and Characterization. 4.Protein Expression. 5.Enzyme Activity Assays. 6.Construction of YSD of Chimeric Scaffoldins. 7.Cyclic Voltammetry (CV) and Chronoamperometry (CA)

COPS DSU DEPARTMENT OF PHARMACEUTICS The genes encoding dockerins of Acetivibrio cellulolyticus and Clostridium thermocellum were cloned and ligated to the C-terminus of Zymomonas mobilis alcohol dehydrogenase and to Pseudomonasputida formaldehyde dehydrogenase by standard methods. The dockerin module of C.thermocellum was also ligated to the C-terminus of CueO (CueO- Ct) of E.coli. All the dockerin-containing enzymes encoding genes have been cloned into the pET15b vector for expression in E. coli, yielding the pET15b-zADH-Ac, pET15b- pFormDH-Ct, and pET15b-CueO-Ct vectors. For controls, the genes encoding the native enzymes without an appended dockerin module were also cloned in the same vector, yielding plasmids pET15b- zADH, pET15b-pFormDH, and pET15b-CueO. Strains and Constructs method

COPS DSU DEPARTMENT OF PHARMACEUTICS 2.0 mL of yeast cells displaying scaffoldin, for which absorbance at a wavelength of 600 nm was 1.0 , were incubated with bacterial lysates containing the expressed enzymes at room temperature for 1 h. 1.0 mL of the bacterial lysates were used for the binding, which was performed in a final volume of 15 ml. As a binding buffer, 50 mM Tris buffer at pH 8.0 with 1 mM CaCl2 was used. Upon binding, the yeast cells were precipitated, and binding was repeated using fresh lysate. After the second binding cycle, the yeast cells were washed four times in the buffer to remove non-specifically bound enzymes. For the CueO-Ct binding, the yeast cells were suspended in 0.1m acetate buffer pH 5.0 containing 1 mm CaCl2 after the last wash. Following binding, they east cells were resuspended in 2.0ml of buffer Enzyme Binding to Scaffoldin

COPS DSU DEPARTMENT OF PHARMACEUTICS Air was continuously purged to the fuel-cells. A potentiostatically controlled anode set to −0.2 V versus Ag/AgCl was used. In all experiments, the cells were left to stabilise overnight, following fuel cell assembly, before characterization was performed. Thecharacterizationoffuelcellperformancewasdonebymeasuringthevoltageofthecells under variable external loads. A background current cell was used as a negative control for all fuel cell experiments and did not contain any yeast. Graphite rods of 5 mm diameter served as both anodes and cathodes. The counter electrode that served for the potentiostatically controlled electrode was of a larger surface area, as described for the CV and CA measurements Biofuel-Cell Assembly and Characterization

COPS DSU DEPARTMENT OF PHARMACEUTICS ADVANTAGES OF ELECTROSOMES It perpetuates the endurance of active drug molecule in the systemic circulation. Deferment the elimination reactions of promptly metabolise drugs and contributes to controlled release. Incorporates both hydrophilic and lipophilic drugs. Intensifies the stability of medicament. Cost of therapy is minimised by reducing the dose per unit formulation Elevate bioavailability especially in water disfavouring drugs. Selective uptake by tissues due to direct drug delivery.

COPS DSU DEPARTMENT OF PHARMACEUTICS DISADVANTAGES OF ELECTROSOMES • The production cost of electrosomes are generally high since these come under the class of nanotherapeutics. • The constituent phospholipids present in lipid vesicular structures may undergo oxidation or hydrolysis.

COPS DSU DEPARTMENT OF PHARMACEUTICS APPLICATION They use enzymatic reactions to catalyse the conversion of chemical energy to electricity in a fuel cell. The use of enzymatic cascades in enzymatic fuel cell anodes resulted in very high power outputs, as the electron density achieved was much higher when the fuel was fully oxidised. It's used as a carrier in drug targeting. Used in the treatment of cancer. Used in studying immune response. Ear targeting Muscle targeting

COPS DSU DEPARTMENT OF PHARMACEUTICS REFERENCE 1.SHEFRIN S, SREELAXMI C. S, VISHNU VIJAYAN, SREEJA C. NAIR.ENZYMOSOMES: A RISING EFFECTUAL TOOL FOR TARGETED DRUG DELIVERY SYSTEM.INT J APP PHARM. 2017;9(6);1-9 2. SZCZUPAK A, AIZIK D, MORAÏS S, VAZANA Y, BARAK Y, BAYER A E, ALFONTA L. THE ELECTROSOME: A SURFACE-DISPLAYED ENZYMATIC CASCADE IN A BIOFUEL CELL’S ANODE AND A HIGH-DENSITY SURFACE-DISPLAYED BIOCATHODIC ENZYME.NANO- MATERIAL.2017 3. WWW.SCIENCE DIRECT.COM

COPS DSU DEPARTMENT OF PHARMACEUTICS TH A NK Y O U
Tags